Rare diseases
Investigational molecules
Locations
Kammakargatan 48, Adolf Fredrik, 111 60 Stockholm, Sweden
Annexin Pharmaceuticals AB (publ) is involved in clinical research focused on retinal vascular disorders, with attention to conditions that affect the blood vessels of the eye and can impair vision.
The sponsor’s research activity in this area centers on ophthalmic disease states associated with retinal circulation and visual dysfunction.
Annexin Pharmaceuticals AB (publ) runs clinical trials in conditions such as Diabetic retinopathy, Retinal vein occlusion, among others.
Clinical trials run by this sponsor – those enrolling participants first.
GermanyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
